Wambeke David J. 4
4 · DiaMedica Therapeutics Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Purchase
Voting Common Shares, no par value per share
2023-11-16$2.46/sh+20,000$49,200→ 527,114 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.